Error: Could not add to watchlist. X
+ Watchlist

Summit Therapeutics PLC

UVF1:GR
Berlin
2.00
EUR
0.01
0.25%
As of 10/20/2017
Open
1.98
Day Range
1.98 - 2.00
Volume
0
Previous Close
1.99
52Wk Range
1.57 - 2.62
1 Yr Return
-6.29%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1.98
Day Range
1.98 - 2.00
Volume
0
Previous Close
1.99
52Wk Range
1.57 - 2.62
1 Yr Return
-6.29%
YTD Return
26.03%
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-
Market Cap (m EUR)
140.906
Shares Outstanding (m)
70.629
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
-0.53%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
Address
85b Park Drive Milton Park
Abingdon, Oxfordshire
Oxfordshire
United Kingdom
Phone
44-123-544-3939
Show More